Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy

BACKGROUND: Interleukin (IL)-35 is a novel inhibitory cytokine and has recently been implicated in tumor immunity. However, the role of IL-35 in prostate cancer (PCa) has not been elucidated. OBJECTIVE: To evaluate the role of plasma IL-35 in the diagnosis and prognosis of PCa in Chinese patients un...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chenchao, Zhang, Jun, Chen, Ye, Wang, Hao, Hou, Jianquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522820/
https://www.ncbi.nlm.nih.gov/pubmed/28761357
http://dx.doi.org/10.2147/OTT.S135873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522820/
https://www.ncbi.nlm.nih.gov/pubmed/28761357
http://dx.doi.org/10.2147/OTT.S135873

Ejemplares similares